W4262

1400W dihydrochloride

>98%, solid

• Synonym(e): N-([3-(aminomethyl)phenyl]methyl)ethanimidamide -dihydrochlorid
• Empirische Formel (Hill-System): C₁₀H₁₅N₃ · 2 HCl
• CAS-Nummer: 214358-33-5
• Molekulargewicht: 250.17
• MDL-Nummer: MFCD03428622
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 24278778
• NACRES: NA.77

Eigenschaften

• Assay: >98%
• Form: solid
• Lagerbedingungen: desiccated
• Ersteller: GlaxoSmithKline
• Versandbedingung: wet ice
• Lagertemp.: −20°C
• SMILES String: Cl[H].Cl[H].CC(=N)NCc1cccc(CN)c1
• InChI: 1S/C10H15N3.2ClH/c1-8(12)13-7-10-4-2-3-9(5-10)6-11;;/h2-5H,6-7,11H2,1H3,(H2,12,13);2*1H
• InChIKey: WDJHSQZCZGPGAA-UHFFFAOYSA-N
• Angaben zum Gen: human ... NOS1(4842) , NOS2(4843) , NOS3(4846)

Beschreibung

Anwendung

1400W dihydrochloride has been used:

• as a strong inhibitor of inducible nitric oxide to analyse its effect on intestinal ischemia/reperfusion (I/R) injury model in rat
• as inducible nitric oxide synthase (iNOS)-selective inhibitor, to elucidate the mechanism of PM10-induced endothelial dysfunction
• to study its efficacy on renal ischemia/ reperfusion injury in rats
• as iNOS inhibitor to investigate its ability to counteract spatial memory deficits after hypobaric hypoxia reoxygenation

Biochem./physiol. Wirkung

1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase (iNOS).

Leistungsmerkmale und Vorteile

This compound is featured on the Nitric Oxide Synthases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type N95 (US)